The drug resistance of multidrug-resistant bacterial organisms in pediatric pneumonia patients.

MDROs drug resistance infectious pneumonia pediatric patients

Journal

American journal of translational research
ISSN: 1943-8141
Titre abrégé: Am J Transl Res
Pays: United States
ID NLM: 101493030

Informations de publication

Date de publication:
2021
Historique:
received: 28 10 2020
accepted: 23 12 2020
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 22 5 2021
Statut: epublish

Résumé

This study aimed to investigate the distribution of multidrug-resistant organisms in pediatric patients with infectious pneumonia and to analyze their resistance and risk factors. Pediatric patients infected with five MDROs (MRSA, MDR-PA, MDRAB, ESBL KP, and ESBL A total of 219 children were included, including 3 cases of mixed infections with MDRO and sensitive bacteria (1.37%), 110 cases of MDRO infections (50.23%), and 106 cases of sensitive bacterial infections (48.40%). Imipramine was sensitive to MDR-PA, MDRAB, ESBL KP, and ESBL Vancomycin or imipenem may result in good clinical outcomes in children treated in the ICU subject to mechanical ventilation, arterial and venous intubation, fiberoptic bronchoscopy, the overuse of antimicrobial drugs, and children with concomitant chronic lung disease or chronic cardiovascular disease.

Identifiants

pubmed: 34017503
pmc: PMC8129425

Types de publication

Journal Article

Langues

eng

Pagination

3309-3315

Informations de copyright

AJTR Copyright © 2021.

Déclaration de conflit d'intérêts

None.

Références

Int J Mol Sci. 2018 Apr 25;19(5):
pubmed: 29693574
Commun Biol. 2018 Sep 3;1:129
pubmed: 30272008
Infect Disord Drug Targets. 2020;20(1):69-75
pubmed: 30277173
Sci Rep. 2018 Jun 21;8(1):9471
pubmed: 29930314
Sci Rep. 2018 Jul 25;8(1):11189
pubmed: 30046138
PLoS One. 2020 Mar 4;15(3):e0220424
pubmed: 32130227
Int J Mol Sci. 2020 Aug 11;21(16):
pubmed: 32796755
Biochim Biophys Acta Biomembr. 2019 Jan;1861(1):34-42
pubmed: 30393205
Mater Des. 2018 Feb 15;140:332-344
pubmed: 29391661
Crit Rev Microbiol. 2019 May;45(3):334-353
pubmed: 31248314
3 Biotech. 2020 Jul;10(7):313
pubmed: 32596098
ACS Infect Dis. 2020 May 8;6(5):1250-1263
pubmed: 32251582
G3 (Bethesda). 2018 Jul 2;8(7):2225-2230
pubmed: 29716961
Sci Rep. 2019 Dec 30;9(1):20365
pubmed: 31889104
PLoS One. 2018 Jun 26;13(6):e0199497
pubmed: 29944697
J Wildl Dis. 2018 Jul;54(3):626-630
pubmed: 29671712

Auteurs

Xianbo Chen (X)

Department of Pediatrics, Wenling Maternal and Child Health Hospital Wenling City, Zhejiang Province, China.

Danfeng Pan (D)

Department of Pediatrics, The First People's Hospital of Wenling Wenling City, Zhejiang Province, China.

Yongzheng Chen (Y)

Department of Pediatrics, Wenling Maternal and Child Health Hospital Wenling City, Zhejiang Province, China.

Classifications MeSH